Curcumin and paclitaxel induce cell death in breast cancer cell lines

Calaf,Gloria M.; Ponce-Cusi,Richard; Carrión,Flavio

doi:10.3892/or.2018.6603

Curcumin and paclitaxel induce cell death in breast cancer cell lines

Authors:
- Gloria M. Calaf
- Richard Ponce-Cusi
- Flavio Carrión
View Affiliations

Affiliations: Instituto de Alta Investigación, Universidad de Tarapacá, Arica 10000, Chile, Programa de Inmunología Traslacional, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile
Published online on: July 26, 2018 https://doi.org/10.3892/or.2018.6603
Pages: 2381-2388

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer that exerts antitumor activity in numerous types of cancer cell. Curcumin (diferuloylmethane), a polyphenol derived from turmeric (Curcuma longa), possesses several properties that could enable it to exert an anticancer effect. Previous reports have demonstrated the synergistic effects of several chemotherapeutic drugs in combination with curcumin. Therefore, the aim of the current study was to evaluate cell death induced by curcumin and paclitaxel alone and in combination in human breast cancer cell lines: MCF7, an epithelial and luminal-like adenocarcinoma cell line triple positive for estrogen and progesterone receptor, and MDA-MB-234, a metastatic human breast cancer cell line triple negative for such receptors, as well as MCF-10F as a normal breast cell line. The results indicated that curcumin and paclitaxel induced apoptosis and necrosis, which was demonstrated through multiple methods, including assays of caspase-3/7 activity, Annexin V, poly(ADP-ribose) polymerase-1 activation and protein expression of caspase-3, nuclear factor (NF)-κB transcription factor and proliferating cell nuclear antigen. The results identified that the combination of curcumin and paclitaxel had a decreased effect on apoptosis in the malignant MDA-MB-231 cell line compared with in MCF7 or MCF-10F. It was demonstrated that the combined treatment with curcumin and paclitaxel resulted in a higher level of apoptosis compared with either substance alone in breast cancer cell lines. Therefore, breast cancer treatment may benefit from the use of a combination of drugs in chemotherapy.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H and Kianmehr M: Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol. 233:5200–5213. 2018. View Article : Google Scholar : PubMed/NCBI
3	Mustacchi G and De Laurentiis M: The role of taxanes in triple-negative breast cancer: Literature review. Drug Des Devel Ther. 9:4303–4318. 2015. View Article : Google Scholar : PubMed/NCBI
4	Bidkar AP, Sanpui P and Ghosh SS: Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles. Nanomedicine (Lond). 12:2641–2651. 2017. View Article : Google Scholar : PubMed/NCBI
5	Karimi G, Vahabzadeh M, Lari P, Rashedinia M and Moshiri M: ‘Silymarin’, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 14:308–317. 2011.PubMed/NCBI
6	Razavi-Azarkhiavi K, Iranshahy M, Sahebkar A, Shirani K and Karimi G: The protective role of phenolic compounds against doxorubicin-induced cardiotoxicity: A comprehensive review. Nutr Cancer. 68:892–917. 2016. View Article : Google Scholar : PubMed/NCBI
7	Stage TB, Bergmann TK and Kroetz DL: Clinical pharmacokinetics of paclitaxel monotherapy: An updated literature review. Clin Pharmacokinet. 57:7–19. 2018. View Article : Google Scholar : PubMed/NCBI
8	Zheng X, Wang C, Xing Y, Chen S, Meng T, You H, Ojima I and Dong Y: SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells. Int J Oncol. 50:893–902. 2017. View Article : Google Scholar : PubMed/NCBI
9	Wang Y, Yu J, Cui R, Lin J and Ding X: Curcumin in treating breast cancer: A review. J Lab Autom. 21:723–731. 2016. View Article : Google Scholar : PubMed/NCBI
10	Robles-Escajeda E, Das U, Ortega NM, Parra K, Francia G, Dimmock JR, Varela-Ramirez A and Aguilera RJ: A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells. Cell Oncol (Dordr). 39:265–277. 2016. View Article : Google Scholar : PubMed/NCBI
11	Ko EY and Moon A: Natural products for chemoprevention of breast cancer. J Cancer Prev. 20:223–231. 2015. View Article : Google Scholar : PubMed/NCBI
12	Księżakowska-Łakoma K, Żyła M and Wilczyński JR: Mitochondrial dysfunction in cancer. Prz Menopauzalny. 13:136–144. 2014.PubMed/NCBI
13	Cui L, Bu W, Song J, Feng L, Xu T, Liu D, Ding W, Wang J, Li C, Ma B, et al: Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway. Arch Pharm Res. 41:299–313. 2018. View Article : Google Scholar : PubMed/NCBI
14	Li J, Dou D, Li P, Luo W, Lv W, Zhang C, Song X, Yang Y, Zhang Y, Xu Y, et al: PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population. Tumour Biol. 39:10104283177069142017. View Article : Google Scholar : PubMed/NCBI
15	Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E and Mannaioni G: HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway. J Cell Mol Med. 21:324–335. 2017. View Article : Google Scholar : PubMed/NCBI
16	Schuhwerk H, Atteya R, Siniuk K and Wang ZQ: PARPing for balance in the homeostasis of poly(ADP-ribosyl)ation. Semin Cell Dev Biol. 63:81–91. 2017. View Article : Google Scholar : PubMed/NCBI
17	Darvishi B, Farahmand L, Eslami-S Z and Majidzadeh-A K: NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer. Tumour Biol. 39:10104283177069192017. View Article : Google Scholar : PubMed/NCBI
18	Baskari S, Govatati S, Madhuri V, Nallabelli N; K PM, ; Naik S, Poornachandar Balka S, Tamanam RR and Devi VR: Influence of autocrine growth hormone on NF-κB activation leading to epithelial-mesenchymal transition of mammary carcinoma. Tumour Biol. 39:10104283177191212017. View Article : Google Scholar : PubMed/NCBI
19	Juríková M, Danihel Ľ, Polák Š and Varga I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016. View Article : Google Scholar : PubMed/NCBI
20	Wang SC: PCNA: A silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci. 35:178–186. 2014. View Article : Google Scholar : PubMed/NCBI
21	Lossi L, Cocito C, Alasia S and Merighi A: Ex vivo imaging of active caspase 3 by a FRET-based molecular probe demonstrates the cellular dynamics and localization of the protease in cerebellar granule cells and its regulation by the apoptosis-inhibiting protein survivin. Mol Neurodegener. 11:342016. View Article : Google Scholar : PubMed/NCBI
22	Gallardo M and Calaf GM: Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol. 48:2534–2542. 2016. View Article : Google Scholar : PubMed/NCBI
23	Ponce-Cusi R and Calaf GM: Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation. Int J Oncol. 48:774–782. 2016. View Article : Google Scholar : PubMed/NCBI
24	Yan G, Graham K and Lanza-Jacoby S: Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog. 52:404–411. 2013. View Article : Google Scholar : PubMed/NCBI
25	Chen D, Dai F, Chen Z, Wang S, Cheng X, Sheng Q, Lin J and Chen W: Dimethoxy curcumin induces apoptosis by suppressing survivin and inhibits invasion by enhancing E-cadherin in colon cancer cells. Med Sci Monit. 22:3215–3222. 2016. View Article : Google Scholar : PubMed/NCBI
26	Ganta S and Amiji M: Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm. 6:928–939. 2009. View Article : Google Scholar : PubMed/NCBI
27	Quispe-Soto ET and Calaf GM: Effect of curcumin and paclitaxel on breast carcinogenesis. Int J Oncol. 49:2569–2577. 2016. View Article : Google Scholar : PubMed/NCBI
28	Calaf GM and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI
29	Calaf GM, Echiburú-Chau C, Wen G, Balajee AS and Roy D: Effect of curcumin on irradiated and estrogen-transformed human breast cell lines. Int J Oncol. 40:436–442. 2012.PubMed/NCBI
30	Calaf GM, Echiburú-Chau C, Roy D, Chai Y, Wen G and Balajee AS: Protective role of curcumin in oxidative stress of breast cells. Oncol Rep. 26:1029–1035. 2011.PubMed/NCBI